Health

The epic rise and fall of Elizabeth Holmes

“4 am Rise and thank God,” the handwritten
memo began. Exercise, meditation, prayer, breakfast (whey and, as she spelt it,
“bannanna”) followed. By 6:45 am, a time when slackers were still fumbling for
the alarm clock, she was at the office of Theranos, the blood-testing company
she founded in 2003.

Holmes had many rules at Theranos: “I am never
a minute late. I show no excitement. ALL ABOUT BUSINESS. I am not impulsive. I
know the outcome of every encounter. I do not hesitate. I constantly make
decisions and change them as needed. I speak rarely. I call bullshit
immediately.”

It worked. Holmes’ resolve was so forceful,
and fit so neatly into the Silicon Valley cliche of achieving the impossible by
refusing to admit it was impossible, that it inspired belief right up to the
moment Monday when a jury officially convicted her of four counts of fraud.

The verdict signalled the end of an era. In
Silicon Valley, where the line between talk and achievement is often vague,
there is finally a limit to faking it.

From Stanford University dropout to Theranos’
$9 billion valuation to conviction, it is an epic rise and fall that will be
chewed over in the coffee shops and juice bars of Palo Alto, California, until
the tech industry departs for a new life in Elon Musk’s and Jeff Bezos’
off-world colonies. For a decade, Holmes fooled savvy investors, hundreds of
smart employees, an all-star board and a media eager to anoint a new star even,
or especially, if she had no qualifications.

Just as Silicon Valley is a cartoonish version
of American notions about the virtues of hard work and getting rich quick, so
Holmes was a heightened version of Silicon Valley.

As her self-improvement scheme made clear, she
was trying to turn herself into a machine that had no time for anything but
work. This was not for her own benefit, of course, but humanity’s. She
perfectly encapsulated the Silicon Valley credo that tech was here to serve us,
and never mind exactly how it did it, the billions it was making or whether it
even worked.

See also  Bikalpadhara proposes names of writer Zafar Iqbal, two others for EC search committee

Whenever anyone — a regulator, an investor, a
reporter — wanted to know a little more about exactly how the Theranos machines
functioned, the company cried “trade secrets.” The real secret, of course, was
that Theranos didn’t have any trade secrets because its machines didn’t work.
But her answer worked for a long time.

Hiding fraud behind the imperatives of secrecy
wasn’t the only way Holmes’ actions were rooted in tradition. Her
self-improvement plan dated back to Ben Franklin but found its most indelible
expression in F. Scott Fitzgerald’s creation of Jay Gatsby, the mysterious,
alluring, handsome millionaire who also ran a few swindles.

Gatsby was practically Holmes’ brother. He,
too, got where he was with a schedule and rules, in his case written inside a
book when he was a striving youth:

5 pm-6 pm: Practice elocution, poise and how
to obtain it

7 pm-9 pm: Study needed inventions

The parallels with Holmes extended even to
Gatsby’s equally loose grasp of spelling. “No more smokeing or chewing,” he
admonished himself.

Gatsby was a bootlegger but also used Wall
Street to cheat. He sold fake bonds. Holmes chose Silicon Valley, the last and
greatest of all human dreams. In the first decade of the century, it promised
to reinvent transportation, friendship, commerce, politics, money.

Blood-testing must have seemed like a breeze
by comparison, especially since Holmes was a natural salesperson, as good at
bending reality as Steve Jobs himself. Here she was in an interview with the
radio show Tech Nation in 2005, explaining what Theranos was all about:

“We focused on creating a customised medicine
tool that could be used in the home by every patient, so that every day, a
patient can get real-time analysis of their blood samples.”

See also  White House official says US is moving toward a time when ‘COVID won’t be a constant crisis’

Who could not applaud such an invention?
Theranos was making a messy, uncertain and time-consuming medical process into
something effortless and painless. “A little teeny needle that pulls a little
teeny drop of blood,” she said. Software would do the rest.

Tech Nation’s host, Moira Gunn, has a master’s
degree in computer science and a doctor of philosophy in mechanical
engineering, but she was dazzled. “How old are you, Elizabeth?” she asked.

“I’m 21,” Holmes said.

Her age was brought up not to knock down her
claims but to underline how impressive they were. “I’m gonna go tell my two
children, they better get off their duffs,” Gunn exclaimed.

Holmes said Theranos’ device was in “the
production phase.” She added, “We hope to release it, actually, to a
pharmaceutical partner around mid-to-late this year.” Thirteen years later,
when the company dissolved, it had never successfully released a device.

In 2005, however, even reinventing
blood-testing at 21 was not enough, so deep was our expectations of genius.
Holmes was asked about her future, and gave the stock Silicon Valley response:
You ain’t seen nothing yet.

Theranos already had the “next generations” of
its device in prototype, she said. It was miniaturised to make it even faster,
to make it “more high-throughput.” It would be automated: “You don’t even have
to touch your finger on the device.”

So in one of the first media interviews Holmes
ever did, she said Theranos had a working device that would be able to analyse
your health without actually touching you. No one called her on it. No wonder
she and her deputy and boyfriend, Ramesh Balwani, the company’s chief operating
officer known as “Sunny,” thought they could brazen it out in the Silicon
Valley tradition until they had something that actually worked.

See also  Bangladesh shuts schools, colleges for two weeks as virus surges

This is a credulous age. William Perry, a
Theranos board member, was secretary of defence under President Bill Clinton, a
mathematician, engineer and Stanford professor. Not, in other words, a fool
with regard to Silicon Valley. Yet he told The New Yorker in 2014 that Holmes
“has sometimes been called another Steve Jobs, but I think that’s an inadequate
comparison. She has a social consciousness that Steve never had. He was a
genius; she’s one with a big heart.”

Jobs, who died in 2011, might as well have
been a recruiter for Theranos. Adam Rosendorff, a lab director at Theranos,
testified during Holmes’ trial that he thought the company was going to be “the
next Apple.” He applied for the job after reading a biography of the Apple
co-founder.

“The whole excitement around Steve Jobs was
very compelling to me,” he said. “I wanted to make a more global impact on
health care and I thought that joining a diagnostics company would help me do
that.”

Rosendorff grew disillusioned before Theranos’
misleading claims were exposed, but Perry stuck it out until December 2016,
when the startup was forced to change its board in a futile attempt to survive.

With believers like these, Holmes’ dream must
have seemed so close that she could hardly fail to grasp it. A couple more late
nights from the engineering team, a few more magazine covers declaring her a
genius, and it would be as good as done.

So where does this conviction leave the rest
of us — her marks, her enablers, her investors and former fans?

Ripe for the next huckster that comes along,
probably. Some Silicon Valley promises are so sweet we just can’t get enough of
them. Immortality. Crypto. Flying cars. Mars. Digital harmony. Wealth beyond
compare.

As Fitzgerald wrote, we will always be a
sucker for the orgastic future that year by year recedes before us.

©2021 The New York Times Company

Related Articles

Back to top button